Azger Dusthackeer

National Institute of Research in Tuberculosis — India

Medicine · Health Sciences

19h-index941citations54works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(29), Mycobacterium research and diagnosis(19), Cancer therapeutics and mechanisms(8), Synthesis and biological activity(7), Bacteriophages and microbial interactions(7)

Publications53 total

Authors’ response
The Indian Journal of Medical Research·2025Open Access
Editorial: Recent advancements in the research models of infectious diseases
Frontiers in Cellular and Infection Microbiology·2025Open Access
Flurbiprofen restores rifampicin and isoniazid sensitivity in multidrug-resistant Mycobacterium tuberculosis putatively by inhibiting efflux pumps Rv0194 and Rv0933
Folia Microbiologica·2025Open Access
Multicentric validation of the PathoDetect™ MTB RIF &amp; INH assay for simultaneous detection of <i>Mycobacterium tuberculosis</i>, &amp; drug resistance to rifampicin &amp; isoniazid in presumptive pulmonary tuberculosis &amp; drug-resistant TB patients
The Indian Journal of Medical Research·2025· 3 citedOpen Access
Biomolecular Interaction of Carnosine and Anti-TB Drug: Preparation of Functional Biopeptide-Based Nanocomposites and Characterization through In Vitro and In Silico Investigations
ACS Omega·2024· 3 citedOpen Access
3,5-disubstituted pyridines with potent activity against drug-resistant <i>Mycobacterium tuberculosis</i> clinical isolates
Future Medicinal Chemistry·2024· 1 citedOpen Access
Advancement in the Molecular Diagnosis of Tuberculosis
2024· 1 cited
A Green perspective on the ability of nanomedicine to inhibit tuberculosis and lung cancer
International Research Journal on Advanced Science Hub·2023· 4 citedOpen Access
Dactylides A−C, three new bioactive 22-membered macrolides produced by Dactylosporangium aurantiacum
The Journal of Antibiotics·2023
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor
PLoS ONE·2023· 5 citedOpen Access
Dodecanoic acid &amp; palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c
International Journal of Microbiology Research·2023· 8 citedOpen Access
Myoinositol and methyl stearate increases rifampicin susceptibility among drug‐resistant <i>Mycobacterium tuberculosis</i> expressing Rv1819c
Chemical Biology & Drug Design·2022· 8 citedOpen Access
Bacillibactin class siderophores produced by the endophyte <i>Bacillus subtilis</i> NPROOT3 as antimycobacterial agents
Letters in Applied Microbiology·2022· 22 cited
Anticancer Activity of Grewia obtusa Fruit on HCT- 116, MCF-7, and HeLa Tumour Cells Besides Antitubercular Activity
Indian Journal of Pharmaceutical Education and Research·2022· 1 citedOpen Access
Chrysomycin A inhibits the topoisomerase I of Mycobacterium tuberculosis
The Journal of Antibiotics·2022· 22 cited
Mycobacterium tuberculosis strain lineage in mixed tribal population across India and Andaman Nicobar Island
World Journal of Microbiology and Biotechnology·2021· 1 cited
Mycobacterium Tuberculosis Strain Lineage in Mixed Tribal Population Across India and Andaman Nicobar Island
Research Square (Research Square)·2021Open Access
Chrysomycin A inhibits the topoisomerase I of <i>Mycobacterium tuberculosis</i>
2021Open Access
A multi-targeting pre-clinical candidate against drug-resistant tuberculosis
Tuberculosis·2021· 22 citedOpen Access
Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance
Journal of Respiration·2021· 134 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Vanaja Kumar(10), Christy Rosaline Nirmal(9), Sam Ebenezer Rajadas(8), Rajesh Mondal(8), B. Mahizhaveni(7), Gomathi Sivaramakrishnan(5), Mahizhaveni Balasubramanian(5), Eruva Vamshi Krishna(4), Sidharth Chopra(4), Sunil Misra(4), Haridas B. Rode(4), Naresh Babu Chilamakuru(4), Geetha Ramachandran(4), Balaji Subramanyam(4), Sameer Hassan(4), Ameer Khusro(4), Chirom Aarti(4), Paul Agastian(4), Selvakumar Subbian(3), Vagolu Siva Krishna(3)